Terms: = Brain cancer AND SMAD2, MADH2, 4087, ENSG00000175387, MGC34440, MGC22139, hMAD-2, MADR2, JV18-1, hSMAD2, JV18 AND Prognosis
17 results:
1. Correlations between the expression of molecules in the TGF-β signaling pathway and clinical factors in adamantinomatous craniopharyngiomas.
Jin L; Cai K; Wu W; Xiao Y; Qiao N; Liu F; Ru S; Cao L; Zhu H; Bai J; Liu C; Li C; Zhao P; Zhang Y; Gui S
Front Endocrinol (Lausanne); 2023; 14():1167776. PubMed ID: 37854185
[TBL] [Abstract] [Full Text] [Related]
2. A preliminary study on the mechanism of VASH2 in childhood medulloblastoma.
Liu W; Fu Y; Wang M; Zhao J; Chen J; Wang Y; Qin H
Sci Rep; 2023 Oct; 13(1):17153. PubMed ID: 37821528
[TBL] [Abstract] [Full Text] [Related]
3. Cyclin-dependent kinase subunit2 (CKS2) promotes malignant phenotypes and epithelial-mesenchymal transition-like process in glioma by activating TGFβ/SMAD signaling.
Feng F; Zhao Z; Cai X; Heng X; Ma X
Cancer Med; 2023 Mar; 12(5):5889-5907. PubMed ID: 36284444
[TBL] [Abstract] [Full Text] [Related]
4. Astrocytic NDRG2-PPM1A interaction exacerbates blood-brain barrier disruption after subarachnoid hemorrhage.
Feng D; Zhou J; Liu H; Wu X; Li F; Zhao J; Zhang Y; Wang L; Chao M; Wang Q; Qin H; Ge S; Liu Q; Zhang J; Qu Y
Sci Adv; 2022 Sep; 8(39):eabq2423. PubMed ID: 36179025
[TBL] [Abstract] [Full Text] [Related]
5. Paradoxical role of β8 integrin on angiogenesis and vasculogenic mimicry in glioblastoma.
Liu Y; Xu X; Zhang Y; Mo Y; Sun X; Shu L; Ke Y
Cell Death Dis; 2022 Jun; 13(6):536. PubMed ID: 35676251
[TBL] [Abstract] [Full Text] [Related]
6. Chelerythrine inhibits the progression of glioblastoma by suppressing the TGFB1-ERK1/2/smad2/3-Snail/ZEB1 signaling pathway.
Zhu M; Niu J; Jiang J; Dong T; Chen Y; Yang X; Liu P
Life Sci; 2022 Mar; 293():120358. PubMed ID: 35092731
[TBL] [Abstract] [Full Text] [Related]
7. p130Cas induces bone invasion by oral squamous cell carcinoma by regulating tumor epithelial-mesenchymal transition and cell proliferation.
Yaginuma T; Gao J; Nagata K; Muroya R; Fei H; Nagano H; Chishaki S; Matsubara T; Kokabu S; Matsuo K; Kiyoshima T; Yoshioka I; Jimi E
Carcinogenesis; 2020 Aug; 41(8):1038-1048. PubMed ID: 31996896
[TBL] [Abstract] [Full Text] [Related]
8. An autocrine ActivinB mechanism drives TGFβ/Activin signaling in Group 3 medulloblastoma.
Morabito M; Larcher M; Cavalli FM; Foray C; Forget A; Mirabal-Ortega L; Andrianteranagna M; Druillennec S; Garancher A; Masliah-Planchon J; Leboucher S; Debalkew A; Raso A; Delattre O; Puget S; Doz F; Taylor MD; Ayrault O; Bourdeaut F; Eychène A; Pouponnot C
EMBO Mol Med; 2019 Aug; 11(8):e9830. PubMed ID: 31328883
[TBL] [Abstract] [Full Text] [Related]
9. HERC3-Mediated SMAD7 Ubiquitination Degradation Promotes Autophagy-Induced EMT and Chemoresistance in Glioblastoma.
Li H; Li J; Chen L; Qi S; Yu S; Weng Z; Hu Z; Zhou Q; Xin Z; Shi L; Ma L; Huang A; Lu Y
Clin Cancer Res; 2019 Jun; 25(12):3602-3616. PubMed ID: 30862693
[TBL] [Abstract] [Full Text] [Related]
10. Inhibin B suppresses anoikis resistance and migration through the transforming growth factor-β signaling pathway in nasopharyngeal carcinoma.
Zou G; Ren B; Liu Y; Fu Y; Chen P; Li X; Luo S; He J; Gao G; Zeng Z; Xiong W; Li G; Huang Y; Xu K; Zhang W
Cancer Sci; 2018 Nov; 109(11):3416-3427. PubMed ID: 30151927
[TBL] [Abstract] [Full Text] [Related]
11. miR-320a functions as a suppressor for gliomas by targeting SND1 and β-catenin, and predicts the prognosis of patients.
Li H; Yu L; Liu J; Bian X; Shi C; Sun C; Zhou X; Wen Y; Hua D; Zhao S; Ren L; An T; Luo W; Wang Q; Yu S
Oncotarget; 2017 Mar; 8(12):19723-19737. PubMed ID: 28160566
[TBL] [Abstract] [Full Text] [Related]
12. Jumonji AT-rich interactive domain 1B overexpression is associated with the development and progression of glioma.
Fang L; Zhao J; Wang D; Zhu L; Wang J; Jiang K
Int J Mol Med; 2016 Jul; 38(1):172-82. PubMed ID: 27246838
[TBL] [Abstract] [Full Text] [Related]
13. Upregulation of p-smad2 contributes to FAT10-induced oncogenic activities in glioma.
Dai B; Zhang Y; Zhang P; Pan C; Xu C; Wan W; Wu Z; Zhang J; Zhang L
Tumour Biol; 2016 Jul; 37(7):8621-31. PubMed ID: 26733179
[TBL] [Abstract] [Full Text] [Related]
14. HOXA13 is a potential GBM diagnostic marker and promotes glioma invasion by activating the Wnt and TGF-β pathways.
Duan R; Han L; Wang Q; Wei J; Chen L; Zhang J; Kang C; Wang L
Oncotarget; 2015 Sep; 6(29):27778-93. PubMed ID: 26356815
[TBL] [Abstract] [Full Text] [Related]
15. TGF-β induced miR-132 enhances the activation of TGF-β signaling through inhibiting SMAD7 expression in glioma cells.
Wang ZH; Zhang QS; Duan YL; Zhang JL; Li GF; Zheng DL
Biochem Biophys Res Commun; 2015 Jul; 463(3):187-92. PubMed ID: 25983322
[TBL] [Abstract] [Full Text] [Related]
16. Involvement of the TGFβ pathway in the regulation of α5 β1 integrins by caveolin-1 in human glioblastoma.
Cosset EC; Godet J; Entz-Werlé N; Guérin E; Guenot D; Froelich S; Bonnet D; Pinel S; Plenat F; Chastagner P; Dontenwill M; Martin S
Int J Cancer; 2012 Aug; 131(3):601-11. PubMed ID: 21901744
[TBL] [Abstract] [Full Text] [Related]
17. Modulation of TGF-beta activity by latent TGF-beta-binding protein 1 in human malignant glioma cells.
Tritschler I; Gramatzki D; Capper D; Mittelbronn M; Meyermann R; Saharinen J; Wick W; Keski-Oja J; Weller M
Int J Cancer; 2009 Aug; 125(3):530-40. PubMed ID: 19431147
[TBL] [Abstract] [Full Text] [Related]
